|
8931 |
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Enthalten in The journal of headache and pain Bd. 23, 18.8.2022, Nr. 1, date:12.2022: 1-19
|
|
|
|
8932 |
Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6–11 Years with Allergic Rhinitis
Enthalten in Clinical drug investigation Bd. 29, 17.9.2012, Nr. 2, date:2.2009: 79-86
|
|
|
|
8933 |
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
Enthalten in Arthritis Research & Therapy Bd. 26, 17.1.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
8934 |
Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
Enthalten in Journal of nuclear cardiology Bd. 24, 25.11.2015, Nr. 1, date:2.2017: 57-65
|
|
|
|
8935 |
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
Enthalten in Schizophrenia Bd. 8, 3.12.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
8936 |
Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study
Enthalten in Neuropsychopharmacology Bd. 50, 15.7.2025, Nr. 11, date:10.2025: 1715-1723
|
|
|
|
8937 |
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
Enthalten in Respiratory research Bd. 15, 11.7.2014, Nr. 1, date:12.2014: 1-10
|
|
|
|
8938 |
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet
Enthalten in Drugs & aging Bd. 37, 28.7.2020, Nr. 9, date:9.2020: 665-676
|
|
|
|
8939 |
Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial
Enthalten in BMC infectious diseases Bd. 19, 15.5.2019, Nr. 1, date:12.2019: 1-8
|
|
|
|
8940 |
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
Enthalten in BMC musculoskeletal disorders Bd. 11, 22.6.2010, Nr. 1, date:12.2010: 1-11
|
|
Administration
